Soft Tissue Sarcoma — Trials

Soft Tissue Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

1,383 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 338
Recruiting: 188
Ph III recruiting: 14
Growth YoY: −16.5%
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (195)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06370871	Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma	withdrawn	Phase 3	0	Boehringer IngelheimINDUSTRY	0	Jul 17, 2024	clinicaltrials
NCT03699176	Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids(ASTEROID 7)	withdrawn	Phase 3	0	BayerINDUSTRY	1	Jan 18, 2020	clinicaltrials